ストックスクリーナーアプリを入手
577.03
0.64%
-4.66
United Therapeutics Corp (UTHR) 最新ニュース
Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.
United Therapeutics’ liver device gets FDA regenerative therapy status - Investing.com
Bioengineered liver for acute liver failure gets key FDA designation - Stock Titan
United Therapeutics (NASDAQ:UTHR) CFO Sells $5,615,000.00 in Stock - MarketBeat
United Therapeutics CFO Edgemond sells $5.6m in UTHR stock By Investing.com - Investing.com Australia
United Therapeutics CFO Edgemond sells $5.6m in UTHR stock - Investing.com
Rothblatt (United Therapeutics) sells $5.3m in UTHR stock - Investing.com
United Therapeutics rises on positive study for cornerstone drug. Why shares could run even higher - MSN
Perpetual Ltd Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR - MarketBeat
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Will United Therapeutics (UTHR) Surpass Expectations in Its Upcoming Earnings Announcement? - Bitget
United Therapeutics' Strong Competitive Edge and Robust Cash Flow Indicate a Sustainable Value Opportunity - Bitget
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock - MarketBeat
UNITED THERAPEUTICS CORP (UTHR.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate - Yahoo Finance
Allspring Global Investments Holdings LLC Has $52.05 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
UTHR Stock Price, Quote & Chart | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win (UTHR) - Seeking Alpha
United Therapeutics Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
BKMC Volume Surges 38-Fold as United Therapeutics Jumps - TipRanks
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics (NASDAQ: UTHR) CFO exercises options and sells 10k shares - Stock Titan
UNITED THERAPEUTICS (UTHR) director exercises options and sells 1,300 shares under 10b5-1 plan - Stock Titan
UNITED THERAPEUTICS (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan
United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo Finance UK
Wells Fargo Raises Price Target for United Therapeutics (UTHR) t - GuruFocus
United Therapeutics (NASDAQ:UTHR) Price Target Raised to $660.00 at HC Wainwright - MarketBeat
United Therapeutics (UTHR): Analyst Greg Harrison Raises Price T - GuruFocus
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo - 247wallst.com
Retirement Systems of Alabama Has $47.39 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last? - Yahoo Finance
United Therapeutics Corp (UTHR) Stock Price Up 13.08% on Mar 30 - GuruFocus
United Therapeutics (UTHR) Achieves Key Milestone in IPF Treatme - GuruFocus
United Therapeutics (UTHR) Sees Positive Results in TETON-1 Stud - GuruFocus
United Therapeutics (UTHR) Tyvaso Shows Promising Results in TET - GuruFocus
United Therapeutics (UTHR) Stock Surges Over 12% - GuruFocus
United Therapeutics (UTHR) Surges Nearly 12% - GuruFocus
Why United Therapeutics (UTHR) Stock Is Up Today - Yahoo Finance
UTHR: TD Cowen Raises United Therapeutics Price Target to $660 | - GuruFocus
United Therapeutics Announces Successful Tyvaso Trial - National Today
United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option - Stock Titan
United Therapeutics Stock Surges Due to Positive Phase 3 Trial Results - timothysykes.com
United Therapeutics Corp (UTHR) Stock Price Quote Today & Current Price Chart - Capital.com
United Therapeutics Rises on Positive Study for Cornerstone Drug. Why Shares Could Run Even Higher. - Barron's
U.S. Indexes Ended Monday Mixed As United Therapeutics Led, Sysco Lagged - Barron's
United Therapeutics Surges Amid Successful Phase 3 Trials - timothysykes.com
Ralinepag Clinical Trials Propel United Therapeutics Stock Soaring - StocksToTrade
United Therapeutics’ Nebulized Tyvaso Achieves Primary Endpoint in TETON-1 Study for Idiopathic Pulmonary Fibrosis, Outperforming Placebo and TETON-2 Results 12 - Minichart
United’s Tyvaso nails endpoints in second phase III IPF trial - BioWorld MedTech
Jefferies raises United Therapeutics stock price target on IPF data By Investing.com - Investing.com India
BofA raises United Therapeutics stock price target on trial data By Investing.com - Investing.com Australia
0.55%
大文字化:
|
ボリューム (24 時間):